The role of selected interleukins in the development and progression of multiple sclerosis—A systematic review
C Grunwald, A Krętowska-Grunwald… - International Journal of …, 2024 - mdpi.com
Multiple sclerosis is a disabling inflammatory disorder of the central nervous system
characterized by demyelination and neurodegeneration. Given that multiple sclerosis …
characterized by demyelination and neurodegeneration. Given that multiple sclerosis …
Advances in immune checkpoint-based immunotherapies for multiple sclerosis: rationale and practice
A Daei Sorkhabi, E Komijani, A Sarkesh… - Cell Communication and …, 2023 - Springer
Beyond the encouraging results and broad clinical applicability of immune checkpoint (ICP)
inhibitors in cancer therapy, ICP-based immunotherapies in the context of autoimmune …
inhibitors in cancer therapy, ICP-based immunotherapies in the context of autoimmune …
Th1 cells contribute to retinal ganglion cell loss in glaucoma in a VCAM-1-dependent manner
C He, K Peng, X Zhu, Z Wang, W Xiu, G Zhang… - Journal of …, 2024 - Springer
Glaucoma is a complex neurodegenerative disorder characterized by the progressive loss of
retinal ganglion cells (RGC) and optic nerve axons, leading to irreversible visual impairment …
retinal ganglion cells (RGC) and optic nerve axons, leading to irreversible visual impairment …
Association of Mediterranean diet adherence with disease progression, quality of life and physical activity, sociodemographic and anthropometric parameters, and …
C Tryfonos, M Chrysafi, SK Papadopoulou… - Aging Clinical and …, 2024 - Springer
Background Multiple sclerosis (MS) constitutes a chronic inflammatory and degenerative
demyelinating disease, which can progressively lead to a broad range of sensorimotor …
demyelinating disease, which can progressively lead to a broad range of sensorimotor …